Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactic acid is a naturally occurring alpha-hydroxy acid (AHA) with diverse therapeutic applications depending on its concentration and route of administration. In dermatology, topical lactic acid (typically in 5-15% concentrations) acts as a keratolytic and humectant, used to treat conditions such as atopic dermatitis, plaque psoriasis, ichthyosis, and xerosis. It is also employed as a non-specific irritant to stimulate hair regrowth in patchy alopecia areata. In gynecology, it is a key component of feminine hygiene products (e.g., Sanofi's Dermacyd line) to maintain the physiological acidic pH of the vaginal mucosa. A novel application involves the intradiscal injection of lactic acid (as the investigational agent STA363 by Stayble Therapeutics) to treat chronic discogenic low back pain and radiculopathy; in this context, it induces connective tissue transformation within the nucleus pulposus to stabilize the intervertebral disc and reduce symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lactic acid.